4//SEC Filing
Chardonnet Laurent 4
Accession 0001562180-22-008192
CIK 0001678660other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 9:13 AM ET
Size
5.5 KB
Accession
0001562180-22-008192
Insider Transaction Report
Form 4
Chardonnet Laurent
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-12-08$4.76/sh+10,000$47,600→ 35,873 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.60 to $4.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]The reported total includes 1,373 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001329010
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 9:13 AM ET
- Size
- 5.5 KB